Rocket Pharma receives US FDA regenerative medicine advanced therapy designation for RP-A601 gene therapy: Cranbury, New Jersey Saturday, July 19, 2025, 15:00 Hrs [IST] Rocket Pha ...

Rocket Lab USA, Inc. (NASDAQ:RKLB) is one of the best space stocks to buy according to hedge funds. Fresh off a Citi analyst ...

The Houston Rockets have steadily improved over the last two seasons, progressing from a bottom-tier lottery team to a 41-win team on the rise, which narrowly m ...

The Spacetech startup has raised $3 Mn in a pre-seed funding round led by a host of undisclosed family offices and angel ...

Welcome to Edition 8.03 of the Rocket Report! We are at an interesting stage in Europe, with its efforts to commercialize ...

HUNTSVILLE, Ala. ( WAFF) - Many came together in the Rocket City on Thursday to celebrate Huntsville’s ticket into the Space Race. The Marshall Space Flight Center was born sixty-five years ago this ...

In March, Rocket Lab announced that the United States Space Force has chosen the Neutron rocket to compete for contracts from ...

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) surged 15% after receiving a key regulatory boost from the U.S. Food and Drug ...

Rocket Pharmaceuticals (NASDAQ:RCKT) said that the U.S. FDA has given regenerative medicine advanced therapy (RMAT) status to their gene therapy, RP-A601, for treating a heart condition known as ...

Investing.com -- Rocket Pharmaceuticals Inc (NASDAQ: RCKT) stock surged 15% after the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to its ...

Rocket Pharmaceuticals received a regenerative medicine advanced therapy designation from the Food and Drug Administration for its heart disease treatment.

Rocket Cos. Inc. closed 36.39% below its 52-week high of $21.38, which the company achieved on September 18th.